Michael Diaz named president, managing physician of Florida Cancer Specialists and Research Institute

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Michael Diaz was named president and managing physician at Florida Cancer Specialists and Research Institute. 

Diaz succeeds Lucio Gordan, who has held the position since 2018.

Diaz joined FCS in 2011 and provides care at two FCS office locations in St. Petersburg. Since November of 2018, he has worked as assistant managing physician for the statewide practice. Diaz serves on the FCS Executive Board and is the FCS director of patient advocacy. 

Gordan is a member of the board of directors for the Community Oncology Alliance and Florida Association of Clinical Oncology. Gordan will continue to practice as a medical oncologist at the FCS Gainesville Cancer Center and serve as chief medical officer of therapeutics and analytics for the statewide practice.

Table of Contents

YOU MAY BE INTERESTED IN

The rapid adoption of glucagon-like peptide-1 receptor agonists (GLP-1RAs), particularly for weight management, represents one of the most significant shifts in metabolic medicine in decades. With millions of people now using medications such as semaglutide and tirzepatide, we are witnessing a fundamental alteration in patient physiology that extends far beyond glucose control and weight loss. As these drugs approach 10% population penetrance in some demographics, the oncology community faces an urgent question: How will this metabolic transformation reshape cancer care?

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login